Analyzing CinCor Pharma Inc. (CINC) By Technical Indicators

0
4
KOSK
KOSK

As of Wednesday close, CinCor Pharma Inc.’s (NASDAQ:CINC) stock was up $0.77, moving up 3.10 percent to $25.63. The average number of shares traded per day over the past five days has been 352,980 shares. 3 times new highs have been achieved over the past 5 days, with a $0.89 gain in that time frame. In the last twenty days, the average volume was 340,255, while in the previous 50 days, it was 309,348.

Since last month, CINC stock retreated -21.64%. Shares of the company fell to $22.43 on 11/21/22, the lowest level in the past month. Since the beginning of this year, CINC’s stock price has risen by 60.19%. However, the stock has declined by -40.60% since its 52-week high.


Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report

Sponsored


CINC stock investors should be aware that CinCor Pharma Inc. (CINC) stock had its last reported insider trading activity 101 days ago on Aug 15. Sofinnova Partners SAS, the 10% Owner of the company, purchased of 133,333 shares for $30.00 on Aug 15. It resulted in a $3,999,990 investment by the insider. 5AM Partners VI, LLC added 600,000 shares at an average price of $30.00 on Aug 15. The insider now owns 3,953,990 shares following the transaction. On Aug 11, 10% Owner GENERAL ATLANTIC, L.P. bought 83,000 shares at $30.00 apiece. The transaction was valued at $2,490,000.

Financial Health

In the three months ended September 29, CinCor Pharma Inc.’s quick ratio stood at 52.00, while its current ratio was 52.00, showing that the company is able to pay off its debt.

While analysts expected CinCor Pharma Inc. to report -$0.61 quarterly earnings, the actual figure was -$0.51 per share, beating the consensus estimate by 16.40%. The liabilities of CinCor Pharma Inc. were 10.18 million at the end of its most recent quarter ended September 29. The value of shareholders’ equity is $43.76 million.

Technical Picture

This quick technical analysis looks at CinCor Pharma Inc.’s (CINC) price momentum. With a historical volatility rate of 56.72%, the RSI 9-day stood at 36.04% on 23 November.

With respect to its five-day moving average, the current CinCor Pharma Inc. price is up by +3.60% percent or $0.89. At present, CINC shares trade -24.55% below its 20-day simple moving average and +25.45% percent above its 100-day simple moving average. However, the stock is currently trading approximately -10.60% below its SMA50 and +5.00% above its SMA200.

Stochastic coefficient K was 26.48% and Stochastic coefficient D was 19.53%, while ATR was 2.05. Given the Stochastic reading of 39.26% for the 14-day period, the RSI (14) reading has been calculated as 36.92%. As of today, the MACD Oscillator reading stands at -0.99, while the 14-day reading stands at -2.14.

With a median target price of $62.00, the current consensus forecast for the stock is $50.00 – $73.00. Based on these forecasts, analysts predict CinCor Pharma Inc. (CINC) will achieve an average price target of $61.83.

LEAVE A REPLY

Please enter your comment!
Please enter your name here